title: [Local treatment of purulent-necrotic complications of diabetic foot syndrome].
abstract: Diabetic foot syndrome is the most frequent and severe complication of diabetes. At present, problem has not been fully resolved, which may lead to the development of more effective ways of correction of purulent complications. The study investigates the efficacy of Hydrogel bandage (Miramistin) combined with physiotherapeutic methods in the treatment of purulent-necrotic lesions of foot. Eighty-three patients with purulent-necrotic lesions of foot were treated at the Clinic of Surgical Diseases №1. The proposed method of treatment demonstrated a greater efficacy than currently available treatments: better cleaning of wounds, reduction of the severity of intoxication and pain, decrease of the duration of inpatient treatment from 28-30 days to 18-19. Hydrogel bandage (Miramistin) is the most efficient drug in prevention and treatment of purulent and infectious complications.
authors.affiliation: Karaganda State Medical University, Department of surgical diseases №1, Republic of Kazakhstan.
authors.forename: V
authors.initials: V
authors.lastname: Feoktistov
authors.affiliation: Karaganda State Medical University, Department of surgical diseases №1, Republic of Kazakhstan.
authors.forename: K
authors.initials: K
authors.lastname: Shakeyev
authors.affiliation: Karaganda State Medical University, Department of surgical diseases №1, Republic of Kazakhstan.
authors.forename: S
authors.initials: S
authors.lastname: Akhmetova
authors.affiliation: Karaganda State Medical University, Department of surgical diseases №1, Republic of Kazakhstan.
authors.forename: M
authors.initials: M
authors.lastname: Zhanassova
authors.affiliation: Karaganda State Medical University, Department of surgical diseases №1, Republic of Kazakhstan.
authors.forename: M
authors.initials: M
authors.lastname: Berkut
mesh_terms: D001548:Benzalkonium Compounds / Q000008:administration & dosage; D048909:Diabetes Complications / Q000188:drug therapy* / Q000503:physiopathology; D017719:Diabetic Foot / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D020100:Hydrogels / Q000008:administration & dosage*; D007328:Insulin / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009336:Necrosis / Q000188:drug therapy* / Q000503:physiopathology; D010146:Pain / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D001548:Benzalkonium Compounds; D020100:Hydrogels; D007328:Insulin; C058048:miramistin